Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Peptides. 2021 Jan 2;137:170477. doi: 10.1016/j.peptides.2020.170477

Table 4.

Percentage of the mean of specific rhACE2 metabolic activity inhibited by MLN-4760 at a concentration of 1 μM.

Substrate Vmax % MLN 4760 displaceable
Ang II 91.5
Ang III 85.4
Ang IV 93.6